About
Cancer 2023 welcomes you to the 2nd International Conference on Cancer Research and Cancer Therapy, which will be held in the stunning city of Prague, Czech Republic from July 27-29, 2023. The theme of this year's conference is Diagnostic and Therapeutical Advancements in Cancer, with a focus on exploring the latest developments in cancer diagnosis and treatment. Cancer 2023 conference is designed to bring together healthcare professionals, researchers, and cancer survivors from all over the world to share knowledge, discuss cutting-edge research, and explore new treatment options for cancer. Attendees will have the opportunity to learn about the latest advances in diagnostics and therapeutics, as well as network with peers and experts in the field.
Through keynote speeches, poster presentations, and panel discussions, we will delve into topics such as immunotherapy, precision medicine, and novel diagnostic tools. This conference will provide a unique platform for exchanging ideas, sharing best practices, and collaborating on new research projects. Join us in Prague for a thought-provoking and informative conference that will enhance your knowledge and understanding of cancer diagnosis and treatment.
We look forward to meeting you in Prague!
Great reasons to attend Cancer 2023
- Stay updated on the latest research and advancements in cancer diagnosis and treatment
- Network with leading experts and professionals
- Hear keynote speeches and attend interactive sessions
- Present your research and receive feedback from experts in the field
- Expand your knowledge and skills in cancer research and cancer therapy
- Learn about the practical applications- Enhance your professional development and contribute to your overall career advancement
Target Audience of Cancer 2023
- Oncologists and medical professionals
- Cancer researchers
- Scientists and academicians
- Industry professionals
- Patient advocacy groups
- Healthcare administrators and policymakers
Call for Abstracts
Cancer 2023 is a platform for exchanging the latest research and advancements in cancer diagnosis and treatment. We invite you to submit your abstract and share your work with a diverse group of experts and professionals in the field.
We encourage abstracts that present original research, case studies, and innovative approaches to cancer research and therapy. Abstracts should be concise and clearly convey the objectives, methods, results, and conclusions of the work.
The conference is seeking abstracts in the following areas:
Submission Guidelines
- Abstracts should be no more than 300 words in length
- Accepted abstracts will be considered for poster or oral presentations
- Abstracts should be submitted online using the conference website
We look forward to receiving your abstract and seeing you at the Cancer 2023 in Prague!
For further information and to submit your abstract, please visit the conference website at Cancer 2023.
Sessions to be Focused:
Track 1: Cancer:
Cancer is a complex disease that affects millions of people worldwide. The conference will cover a broad range of topics related to cancer, including risk factors, diagnosis, treatment, and prevention. We will hear from experts in the field who will share their latest research findings and discuss emerging trends in cancer treatment.
Track 2: Clinical Cancer:
Cancer remains a significant health challenge worldwide, with millions of new cases diagnosed each year. One of the key topics we will cover in this session is the importance of accurate and timely diagnosis. Early detection of cancer is critical for successful treatment, and clinicians play a vital role in identifying cancer in its earliest stages. We will also explore the latest treatment options for cancer, including surgery, radiation therapy, chemotherapy, and immunotherapy.
Track 3: Cancer Diagnosis:
Early detection of cancer is essential for successful treatment, and accurate and timely diagnosis is critical in achieving this goal. We will explore the latest diagnostic tools and techniques that have been developed to identify cancer in its earliest stages. One of the key topics we will cover in this session is cancer screening. In this session, we will discuss the latest screening guidelines for common cancers, including breast, colorectal, lung, and prostate cancer.
Track 4: Tumour Invasion and Metastasis:
Tumour invasion and metastasis are among the most challenging aspects of cancer to treat. Cancer cells can spread to other parts of the body through the bloodstream or lymphatic system, making it difficult to control the disease. We will explore the latest research in understanding the mechanisms behind tumour invasion and metastasis, and also discuss how these factors interact with cancer cells to promote tumour invasion and metastasis.
Track 5: Cancer Treatment and Therapy:
Cancer treatment has come a long way in recent years, and new therapies are being developed at an unprecedented pace. We will explore the latest research in cancer treatment and how these therapies are being used to improve the lives of cancer patients. The key topics we will cover in this session is the use of precision medicine in cancer treatment and also explore the latest developments in immunotherapy, which has emerged as a powerful new approach to cancer treatment.
Track 6: Chemotherapy:
Chemotherapy is a cornerstone of cancer treatment and has been used for decades to kill cancer cells. However, chemotherapy can also cause significant side effects, and new developments in chemotherapy are focused on improving its effectiveness while minimizing side effects. The key topics we will cover in this session is the use of combination chemotherapy. Combination chemotherapy involves using two or more drugs together to improve treatment outcomes.
Track 7: Immunotherapy:
Immunotherapy is a rapidly developing field of cancer treatment that uses the body's own immune system to fight cancer. Immunotherapy has shown great promise in treating a wide range of cancers, including melanoma, lung cancer, and bladder cancer. One of the key topics we will cover in this session is the use of immune checkpoint inhibitors. We will also discuss the latest research in immune checkpoint inhibitors and how they are being used to treat different types of cancers and we will also explore the latest developments in combination immunotherapy. Combination immunotherapy involves using two or more drugs together to improve treatment outcomes.
Track 8: Radiation therapy for cancer:
Radiation Therapy session of the Cancer Conference, we will discuss the latest developments in radiation therapy, including new techniques, combination therapies, and approaches to minimizing side effects. Radiation therapy is a common treatment for many types of cancer. It involves using high-energy radiation to kill cancer cells and shrink t-+umors. While radiation therapy can be highly effective, it can also cause side effects, including fatigue, skin irritation, and damage to healthy tissues.
Track 9: Stem cell Therapy:
Stem cell therapy has emerged as a promising approach for cancer treatment, as it involves using stem cells to replace the damaged or destroyed cells in the body caused by cancer or its treatment. During the conference session, the experts will discuss the various types of stem cells used for cancer therapy, including embryonic stem cells, induced pluripotent stem cells, and adult stem cells. They will also discuss the different methods used to deliver stem cells to the body, such as intravenous injection, bone marrow transplantation, and direct injection into the tumour.
Track 10: Gene Therapy:
At the cancer conference session on gene therapy, researchers and experts from various institutions and organizations gathered to discuss the latest advancements and breakthroughs in the field of gene therapy for cancer treatment. Gene therapy is an innovative approach to cancer treatment that involves manipulating genes to fight cancer cells. The therapy works by either replacing, repairing, or editing genes to correct or eliminate the genetic abnormalities that lead to cancer development.
During the conference session, the experts will also discuss the various types of gene therapies used for cancer treatment, including viral gene therapy, non-viral gene therapy, and gene editing.
Track 11: Breast Cancer:
At the cancer conference session on breast cancer, researchers and experts from various institutions and organizations gathered to discuss the latest advancements and breakthroughs in the diagnosis, treatment, and prevention of breast cancer. Breast cancer is one of the most common types of cancer affecting women worldwide. The conference session focused on several aspects of breast cancer, including the latest advancements in early detection, new treatment options, and the importance of personalized care.
Track 12: Lung Cancer:
Lung cancer is one of the most common and deadliest forms of cancer worldwide. The conference session focused on several aspects of lung cancer, including the latest advancements in early detection, new treatment options, and the importance of personalized care. The experts will also discuss the role of imaging techniques, such as CT scans and PET scans, in early lung cancer detection. They also discussed the importance of smoking cessation and reducing exposure to environmental pollutants in preventing lung cancer.
Track 13: Prostate Cancer:
Prostate cancer is the second most common cancer among men worldwide. The conference session focused on several aspects of prostate cancer, including the latest advancements in early detection, new treatment options, and the importance of personalized care. The experts discuss the role of screening techniques, such as the prostate-specific antigen (PSA) blood test, in early prostate cancer detection. They also discuss the benefits and limitations of genetic testing for prostate cancer risk assessment and the importance of family history and personal risk factors in determining the appropriate screening guidelines.
Track 14: Blood Cancer:
Blood cancer, also known as haematological malignancy, affects the blood, bone marrow, and lymphatic system. The conference session focuses on several aspects of blood cancer, including the latest advancements in early detection, new treatment options, and the importance of personalized care. The experts discuss the role of laboratory tests, such as blood tests and bone marrow biopsies, in diagnosing blood cancer. They also discuss the importance of genetic testing in identifying specific gene mutations that may be driving cancer growth and guiding treatment decisions.
Track 15: Oral and Oropharyngeal Cancer
The cancer conference session on Oral and Oropharyngeal Cancer provided a comprehensive overview of the latest developments and breakthroughs in the diagnosis, treatment, and prevention of these types of cancer. It showcased the importance of personalized care and the need for continued research and clinical trials to improve outcomes for patients with oral and oropharyngeal cancer.
Track 16: Cancer Biomarkers:
Cancer biomarkers are substances, such as proteins or DNA, that are produced by cancer cells or by the body in response to cancer. The conference session focused on the importance of identifying and validating cancer biomarkers to improve cancer diagnosis, prognosis, and treatment.
In this session, the experts discuss the various types of cancer biomarkers, including genetic, epigenetic, and protein biomarkers, and the use of different technologies, such as next-generation sequencing and mass spectrometry, to identify and analyse these biomarkers.
Track 17: Cancer Genetics:
The cancer conference session on Cancer Genetics is a crucial part of any cancer conference. This session focuses on the latest research and findings related to the genetics of cancer, including the identification of genetic mutations that contribute to the development and progression of cancer, as well as new methods for diagnosing and treating cancers based on an understanding of their genetic makeup.
Track 18: Carcinogenesis:
The cancer conference session on carcinogenesis is an important part of any conference related to cancer research and treatment. This session focuses on the underlying processes that cause healthy cells to become cancerous, as well as the mechanisms that contribute to the growth and spread of cancer cells throughout the body.
During the session, leading experts in the field of carcinogenesis will present their latest research findings, including insights into the genetic and environmental factors that contribute to the development of cancer.
Track 19: Cancer Nursing:
Cancer Nursing is an important part of any conference related to cancer care. During the session, leading experts in the field of cancer nursing will present their latest research findings, as well as share their insights and experiences in caring for cancer patients. These presentations may cover a range of topics, including the latest advances in cancer treatment and the impact of these treatments on patients' physical and emotional well-being, as well as the importance of patient-centred care and the role of the nurse in supporting patients and their families throughout the cancer journey.
Track 20: Cancer Prevention:
During the session, leading experts in the field of cancer prevention will present their latest research findings, as well as share their insights and experiences in preventing cancer. These presentations may cover a range of topics, including the latest advances in cancer screening and early detection, as well as lifestyle factors that can impact cancer risks, such as diet, exercise, and smoking cessation.
Track 21: Regenerative Medicine:
Regenerative medicine is a rapidly evolving field that focuses on harnessing the body's natural ability to repair and regenerate damaged tissues and organs. In the context of cancer treatment, regenerative medicine approaches are being developed to help repair the damage caused by cancer and its treatments, as well as to regenerate healthy tissues and organs that have been affected by cancer.
During the session, leading experts in the field of cancer regenerative medicine will present their latest research findings, as well as share their insights and experiences in developing and applying regenerative medicine approaches in the context of cancer treatment.
Track 22: Metastasis:
During the session, leading experts in the field of cancer metastasis will present their latest research findings, as well as share their insights and experiences in understanding and preventing this complex process. These presentations may cover a range of topics, including the latest advances in cancer biology, imaging techniques, and drug development for metastatic cancer.
One key area of focus in the cancer conference session on cancer metastasis is the identification of new targets for therapy. Another important theme in the cancer conference session on cancer metastasis is the development of new drugs and treatment approaches for metastatic cancer.
Track 23: Drug Development in Cancer:
During the session, leading experts in the field of drug development for cancer treatment will present their latest research findings, as well as share their insights and experiences in developing and testing new drugs. These presentations may cover a range of topics, including the latest advances in cancer biology, drug discovery, and clinical trial design.
One key area of focus in the cancer conference session on drug development in cancer is the development of new targeted therapies Another important theme in the cancer conference session on drug development in cancer is the testing of existing drugs in new ways.
Track 24: Clinical Trials in Cancer:
One key area of focus in the cancer conference session on clinical trials is the development of innovative trial designs. Researchers are exploring new ways to design trials that are more efficient, cost-effective, and can better address specific patient populations. This includes adaptive trial designs that allow for changes to the trial protocol based on interim results, as well as basket and umbrella trials that allow for the evaluation of multiple treatments or patient populations in a single trial. Another important theme in the cancer conference session on clinical trials is the use of biomarkers to guide treatment selection.
Market Analysis
Oncology devices are medical devices that are used to diagnose, manage, and treat cancer. Oncology devices are classified into two types: brachytherapy devices and endoscopic devices. Endoscopic devices are medical devices that are used to diagnose, manage, and treat cancer. It is used to peer inside a body cavity or organ. These are used in a variety of therapies, including chemotherapy, hormone therapy, biotherapy/immunotherapy, and radiation therapy, and are used by a variety of end-users, including hospitals and cancer research institutes.
The oncology devices market research report is one of a series of new reports from The Business Research Company that provides oncology devices market statistics such as oncology devices industry global market size, regional shares, competitors with oncology devices market shares, and detailed oncology devices market statistics. Market segments for oncology devices, market trends, and opportunities, and any additional information you may require to thrive in the oncology devices industry. This oncology devices market research report provides a comprehensive view of everything you require, including an in-depth analysis of the industry's current and future scenarios.
The global oncology devices market is expected to grow at a compound annual growth rate (CAGR) of 17.9% from $91.47 billion in 2021 to $107.81 billion in 2022. The Russia-Ukraine war, at least in the short term, hampered global economic recovery from the COVID-19 pandemic. The conflict between these two countries has resulted in economic sanctions against a number of countries, a rise in commodity prices, and supply chain disruptions, resulting in inflation across goods and services and affecting many markets around the world. The oncology devices market is expected to grow at a 19% CAGR to $216.35 billion by 2026. The growing number of cancer cases worldwide is expected to drive demand for oncology devices.